NSE: CIPLA - Cipla Limited

Yield per half year: -7.69%
Dividend yield: +1.39%
Sector: Healthcare

Cipla Limited

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
6/10
29.04 59.63 -51.3% 30.2 -3.85%
P/S 4.64 9.32 -50.19%
P/BV 4.47 6.64 -32.75%
P/FCF 35.81 -106.44 -133.65%
Ev/Ebitda 17.8 141.59 -87.43%
Ev/S 4.64 9.59 -51.63%
Ev/FCF 42.95 -85.26 -150.38%
E/P 0.0413 0.0211 95.97%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
26.07 5.7 357.52% 23.9 +9.08%
ROE 16.45 10.72 53.37%
ROA 13.26 7.64 73.57%
ROIC 14.41 15.91 -9.44%
ROS 15.99 -4.5 -455.26%
ROCE 21.56 13.07 64.9%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.0833 121.74 -99.93% 0.1926 -56.77%
Nеt Debt/Ebitda -0.012 121.47 -100.01%
Debt/Ratio 0.0171 0.145 -88.21%
Debt/Equity 0.0985 1.97 -94.99%
Debt/Net Income 0.1357 5.06 -97.32%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
3.48/10
1.39 9.57 -85.47% 0.7464 +86.22%
Number of years of dividend growth 1 0.9146 9.33%
DSI 0.9286 0.8306 11.79%
Average dividend growth 9.3 -3.39 -374.46%
Average percentage for 5 years 0.7464 14.83 -94.97%
Average percentage for payments 16.69 24.67 -32.34%
Difference from average difference in sector -8.18

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
7/10
54.3 42.4 28.07%
Growth impulse Ebitda in 5 years 93.21 26.84 247.28%
Growth impulse Net Income in 5 years 166.5 77.79 114.04%
Growth impulse FCF in 5 years 34.62 -25.16 -237.6%
Growth impulse EPS in 5 years 166.09 -13.77 -1306.17%
IP Score
6.71/10

Similar companies

Divi's Laboratories Limited

Torrent Pharmaceuticals Limited

Sun Pharmaceutical Industries Limited

Dr. Reddy's Laboratories Limited

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription